Cartron, G., Hourcade-Potelleret, F., Morschhauser, F., Salles, G., Wenger, M., Truppel-Hartmann, A. and Carlile, D. J. (2016) “Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma”, Haematologica. Pavia, Italy, 101(2), pp. 226-234. doi: 10.3324/haematol.2015.133421.